高原地区单中心先天性心脏病手术治疗136例经验总结
Summary of Experience of 136 Cases of Con-genital Heart Disease in Plateau Area
DOI: 10.12677/ACM.2023.1392102, PDF,   
作者: 王为新, 郑善光*:济宁医学院附属医院心脏外科,山东 济宁;李成棽, 完玛南杰:青海红十字医院小儿外科,青海 西宁
关键词: 高原先天性心脏病肺动脉高压Plateau Area Congenital Heart Disease Pulmonary Artery Hypertension
摘要: 目的:探讨高原地区先天性心脏病发病特点及治疗策略。方法:回顾性分析2019年6月~2020年7月青海红十字医院收治的136例高原地区先天性心脏病患者病例特点、手术治疗方法及围术期管理经验,分析其术前、术中和术后等治疗因素对患者预后的影响。结果:高原地区先天性心脏病病种复杂,房间隔缺损及动脉导管未闭绝大多数可以经皮封堵治疗,效果良好;复杂先心病矫治术后患儿恢复与手术技术、术后管理经验及患儿就诊时机等密切相关,合并肺动脉高压患者的治疗相对困难,有高原地区的自身特点。结论:高原地区先心病救治单位的治疗技术需注重复杂先心病的个体化治疗,早诊早治仍是治愈先天性心脏病的关键之一。
Abstract: Objective: To investigate the characteristics and strategies of congenital heart disease in plateau area. Methods: The characteristics of 136 congenital heart disease cases in plateau area admitted in Qinghai Red Cross Hospital from June 2019 to July 2020, surgical treatment methods and perioper-ative management experience, and the influence of preoperative, intraoperative and postoperative treatment factors on patient prognosis were analyzed. Results: Plateau congenital heart disease is complex, and atrial septal defect and patent ductus arteriosus can be treated with percutaneous oc-clusion and have good effects; the recovery of complicated congenital heart disease is closely related to surgical technique, postoperative management experience and the treatment of pulmonary hy-pertension. The treatment of pulmonary hypertension of congenital heart disease in plateau area has certain difficulty. Conclusion: The treatment technology of the plateau area of congenital heart disease treatment unit should be the individualized treatment of complex congenital heart disease, and early diagnosis and early treatment is still one of the key to cure congenital heart disease.
文章引用:王为新, 郑善光, 李成棽, 完玛南杰. 高原地区单中心先天性心脏病手术治疗136例经验总结[J]. 临床医学进展, 2023, 13(9): 15035-15040. https://doi.org/10.12677/ACM.2023.1392102

参考文献

[1] 陈秋红, 路霖, 祁国荣, 等. 高原地区先天性心脏病并发肺动脉高压的调查分析[J]. 中华医学杂志, 2011, 91(44): 3120-3122.
[2] 汪曾炜, 刘维永, 张宝仁. 心脏外科学[M]. 北京: 人民军医出版社, 2003: 850.
[3] Ge, R.L., Ma, R.Y., Bao, H.H., et al. (2009) Changes of Cardiac Structure and Function in Pediatric Patients with High Altitude Pulmonary Hypertension in Tibet. High Altitude Medicine & Biology, 10, 247-252. [Google Scholar] [CrossRef] [PubMed]
[4] 关于我国高原病命名、分型及诊断标准(1995年中华医学会标准)及其英译本的介绍[J]. 高原医学杂志, 2010, 20(1): 5-9.
[5] Chen, Q.H., Wang, X.Q., Qi, S.G., et al. (2008) Cross-Sectional Study of Congenital Heart Disease among Tibetan Children Aged from 4 to 18 Years at Different Alti-tudes in Qinghai Province. Chinese Medical Journal (England), 121, 2469-2472. [Google Scholar] [CrossRef
[6] 柏争鸣, 王栋军, 郑芳芳. 小儿高原性心脏病175例临床分析[J]. 西南军医, 2008, 10(3): 60-61.
[7] 宋晶慧, 邹登朗, 祁得胜, 等. 高原低氧环境对心肌细胞影响的研究进展[J]. 生态科学, 2023, 42(4): 258-264.
[8] 盖祥云, 林鹏程, 何彦峰, 才让南加. 低氧性肺动脉高压中低氧性肺血管收缩的作用[J]. 中国药理学通报, 2016, 32(6): 768-772.
[9] 韩泽乾, 董红梅, 罗勇军. 高原心脏病防治研究进展[J]. 人民军医, 2017, 60(8): 822-824.
[10] 马海红, 李洪英, 胡雪梅, 范娜. 彩色超声心动图检查在高原心脏病肺动脉高压诊断中的临床价值[J]. 中国医学装备, 2016, 13(10): 52-55.
[11] Kojonazarov, B., Isakova, J., Imanov, B., et al. (2012) Bosentan Reduces Pulmonary Artery Pressure in High Altitude Residents. High Altitude Medicine & Biology, 13, 217-223. [Google Scholar] [CrossRef] [PubMed]
[12] Xu, X.Q. and Jing, Z.C. (2009) High-Altitude Pulmonary Hypertension. European Respiratory Review, 18, 13-17. [Google Scholar] [CrossRef] [PubMed]
[13] 管涛, 王黎明. 高海拔地区动脉导管未闭合并重度肺动脉高压的介入治疗[J]. 临床荟萃, 2012, 27(16): 1431-1432.
[14] Abman, S.H. (2013) Inhaled Nitric Oxide for the Treat-ment of Pulmonary Arterial Hypertension. Handbook of Experimental Pharmacology, 218, 257-276. [Google Scholar] [CrossRef
[15] Nair, J., Orie, J. and Lakshminrusimha, S. (2012) Successful Treatment of a Neonate with Idiopathic Persistent Pulmonary Hypertension with Inhaled Nitric Oxidevia Nasal Cannula without Mechanical Ventilation. AJP Reports, 2, 29-32.
[16] 夏燕亮, 马如海, 陈宏, 等. 西地那非治疗高原地区先天性心脏病合并重度肺动脉高压的疗效和安全性探讨[J]. 中国循环杂志, 2014, 29(9): 702-705.
[17] 于亦华. 西地那非在高原地区先天性心脏病合并肺动脉高压中的应用[J]. 临床心血管病杂, 2010, 26(10): 787-788.
[18] 伍琼, 贾镭, 荆志成, 等. 曲前列尼尔治疗肺动脉高压的研究进展[J]. 中华心血管病杂志, 2017, 45(9): 810-813.
[19] 黄坤, 刘迪凡, 张刚成, 等. 简化优化肺高血压的诊治——《2022ESC/ERS肺高血压诊断和治疗指南》[J]. 临床心血管病杂志, 2022, 38(10): 776-779.
[20] Galiè, N., Humbert, M., Vachiery, J.L., et al. (2016) 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension: The Joint Task Force for the Diagno-sis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respira-tory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Heart Journal, 37, 67-119. [Google Scholar] [CrossRef] [PubMed]
[21] 中华医学会心血管病学分会肺血管病学组, 中华心血管病杂志编辑委员会. 中国肺高血压诊断和治疗指南 2018 [J]. 中华心血管病杂志, 2018, 46(12): 933-964.